Related Experiment Video
Updated: Dec 27, 2025

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.2K
Tuberculosis case fatality in India: a systematic review and meta-analysis
Sophie Huddart1,2, Anita Svadzian1,2, Vaidehi Nafade1,2
1Epidemiology & Biostatistics, McGill University, Montreal, Quebec, Canada.
BMJ Global Health
|March 6, 2020
Summary
India
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- India contributes significantly to global tuberculosis (TB) deaths.
- The World Health Organization's End TB Strategy aims to reduce the global case fatality ratio (CFR) to below 5%.
Purpose of the Study:
- To systematically review and estimate the case fatality ratios (CFRs) among Indian patients with TB during and after treatment.
- To identify factors associated with increased TB case fatality in India.
Main Methods:
- Systematic search of Medline, Embase, and Global Health databases for studies published between 2006 and 2019.
- Inclusion of cohort studies and intervention control arms following Indian TB patients.
- Pooled CFR estimation using random-effects models and meta-regression for associated factors.
Main Results:
- A pooled treatment phase CFR of 5.16% was estimated, reducing to 3.78% in high-quality studies.
- Higher CFRs were observed in pediatric, drug-resistant, and HIV-infected TB patients.
- Poor study quality and treatment in tertiary centers were associated with increased CFR.
Conclusions:
- India's treatment CFRs align with WHO targets, but methodological issues persist in most studies.
- Key patient groups, including pediatric, drug-resistant, and HIV-infected TB patients, require further research.
- Enhanced high-quality reporting on patient outcomes is crucial for improving TB care evidence.
Related Concept Videos
Pulmonary Tuberculosis I
755
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
755
Pulmonary Tuberculosis V
482
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
482
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III
818
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
818
Pulmonary Tuberculosis IV
436
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
436
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K

